Prospective 3-month study on the efficacy of UV-free blue light in mild psoriasis vulgaris treatment

8Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Introduction: Psoriasis is one of the most common chronic skin diseases affecting up to 2% of the general population. In recent years, an important direction for the decelopment of treatment for psoriasis has been the use of blue light emitted by LED lamps. Aim: To ecaluate the efficacy of blue-light emitting decice in psoriasis culgaris treatment. Material and methods: The study incolced 30 adults with a mild form of psoriasis culgaris not preciously receicing biological treatment and other forms of phototherapy. Participants of the study used a decice emitting blue LED light for 3 months. Each participant receiced a decice for use at home, with which he/she exposed 2 psoriatic lesions located on the limbs. Before and after the study, the secerity of the disease was ecaluated using PASI, DLQI and LPSI. Results: During 3 months of the therapy a statistically significant decrease in the mean LPSI in both treated locations) and DLQI was noted (LPSI decrease from 5.25 ±1.82 to 1.98 ±1.74, p < 0.0001; DLQI from 7.36 ±5.59 before the study to 5.23 ±4.62 after the study. Conclusions: Our results confirm that phototherapy using blue LED light is both a safe and highly effectice way to treat psoriasis.

Author supplied keywords

Cite

CITATION STYLE

APA

Lesiak, A., Bednarski, I. A., & Narbutt, J. (2021). Prospective 3-month study on the efficacy of UV-free blue light in mild psoriasis vulgaris treatment. Postepy Dermatologii i Alergologii, 38(3), 446–449. https://doi.org/10.5114/ADA.2021.107931

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free